Tezuka Ayano, Higo Kenjuro, Nakamukae Yuta, Nishihara Sanae, Kamikawa Masaki, Shimofuku Chihiro, Kawazoe Kazumasa, Ohishi Mitsuru
Departments of Cardiovascular Medicine, Japanese Red Cross Kagoshima Hospital, Japan.
Departments of Clinical Laboratory Unit, Japanese Red Cross Kagoshima Hospital, Japan.
Intern Med. 2019 Feb 15;58(4):535-539. doi: 10.2169/internalmedicine.0997-18. Epub 2018 Oct 17.
Midventricular obstructive hypertrophic cardiomyopathy (MVOHCM) is a rare form of hypertrophic cardiomyopathy (HCM). An 80-year-old man was administered bisoprolol and warfarin therapies as treatment for MVOHCM with an apex aneurysm due to myocardial damage and intra-aneurysmal thrombus not complicated by atrial fibrillation. The pressure gradient in the midventricle successfully improved from 53.9 to 21.8 mmHg, and the intra-aneurysmal thrombus disappeared.
心室中部梗阻性肥厚型心肌病(MVOHCM)是肥厚型心肌病(HCM)的一种罕见形式。一名80岁男性因心肌损伤和动脉瘤内血栓形成但无房颤并发症的情况,接受比索洛尔和华法林治疗以治疗伴有心尖部动脉瘤的MVOHCM。心室中部的压力梯度成功地从53.9 mmHg降至21.8 mmHg,动脉瘤内血栓消失。